Violet Therapeutics

Cambridge, United States

Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.

May 2026

Seed

Health Care Medical Therapeutics

Top Investors

UTEC - The University of Tokyo Edge Capital PartnersDementia Discovery FundOno Venture InvestmentMass General Brigham VenturesLifespan Vision Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Violet Therapeutics

Who are Violet Therapeutics's investors?

Violet Therapeutics's investors include UTEC - The University of Tokyo Edge Capital Partners, Dementia Discovery Fund, Ono Venture Investment, Mass General Brigham Ventures, Lifespan Vision Ventures.

Where is Violet Therapeutics headquartered?

Violet Therapeutics is headquartered in Cambridge, United States.

What does Violet Therapeutics do?

Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.

What stage is Violet Therapeutics at?

Violet Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 13, 2026.

MLA

"Violet Therapeutics — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/violet-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2026). Violet Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/violet-therapeutics

Wikipedia (cite web)

{{cite web |title=Violet Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/violet-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 13, 2026.